Optimizing the Risk-benefit Conversation with Inflammatory Bowel Disease Patients. Canadian IBD Today, Toronto, Canada, v. 4, n. 1, p. 23–30, 2026. DOI: 10.58931/cibdt.2026.4155. Disponível em: https://canadianibdtoday.com/article/view/4-1-Singh. Acesso em: 2 mai. 2026.